News Release

Printer Friendly Version View printer-friendly version
« Back
Zogenix to Participate in Stifel 2014 Healthcare Conference

SAN DIEGO, Nov. 12, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of pain-related conditions and central nervous system disorders, today announced that Zogenix management will present at the Stifel 2014 Healthcare Conference in New York, NY on November 18, 2014.

Event: Stifel 2014 Healthcare Conference
Date: Tuesday, November 18, 2014
Place: New York City
Time: 11:30 am ET/ 08:30 am PT

The presentation will be webcast live and archived for 30 days on Zogenix' Investor Relations website at ir.zogenix.com. Management will also be available to participate in one-on-one meetings at the conference.

About Zogenix

Zogenix, Inc. (Nasdaq:ZGNX) is a pharmaceutical company committed to developing and commercializing therapies that address specific clinical needs for people living with pain-related conditions and CNS disorders who need innovative treatment alternatives to help them return to normal daily functioning.

FPR

CONTACT: Investors
         Zack Kubow, The Ruth Group
         646.536.7020, zkubow@theruthgroup.com
Zogenix